๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias

โœ Scribed by Muge Aydin-Sayitoglu; Ozden Hatirnaz; Nevin Erensoy; Ugur Ozbek


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
116 KB
Volume
81
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


CYP1A1 CYP2E1 and GSTM1 polymorphisms ar
โœ Shunji Morita; Masahiko Yano; Hitoshi Shiozaki; Toshimasa Tsujinaka; Chikara Ebi ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 43 KB ๐Ÿ‘ 1 views

We investigated the genetic polymorphisms of CYP1A1, CYP2E1 and GSTM1 in Japanese esophageal cancer patients (n = 53) with a histological diagnosis of squamous-cell carcinoma, to determine whether susceptibility to esophageal cancer is associated with these polymorphisms. There were no significant d

Combined analysis of germline polymorphi
โœ Jin W. Kim; Chun G. Lee; Yong G. Park; Kyung S. Kim; In-K. Kim; Yeo W. Sohn; Hon ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 103 KB

The authors established the genotype frequencies of cytochrome P450 (CYP1A1/MspI, CYP2E1/PstI, and CYP2E1/DraI), glutathione-S-transferase (GSTM1 and GSTT1), and p53 (exon 4/AccII and intron 3/16-base pair duplication) gene polymorphisms in cervical carcinoma patients and controls and evaluated the

Genotyping of the CYP1A1 and GSTM1 genes
โœ Yoshinori Nimura; Shiro Yokoyama; Minoru Fujimori; Takahisa Aoki; Wataru Adachi; ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 123 KB ๐Ÿ‘ 1 views

thione-S-transferases. A high risk lung carcinoma group has been reported to have specific polymorphisms of the cytochrome P450 (CYP1A1) gene and the glutathi-

Differential in vivo effects of ฮฑ-naphth
โœ Christopher J. Sinal; Christopher D. Webb; John R. Bend ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 225 KB

Male Sprague-Dawley rats were treated intraperitoneally with corn oil, the aryl hydrocarbon receptor (AHR) agonist b-naphthoflavone (bNF), or the relatively weak AHR agonist โฃ-naphthoflavone (โฃNF). Animals treated with bNF experienced a significant loss (12%) of total body mass over 5 days and a dra